SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-029734
Filing Date
2023-08-21
Accepted
2023-08-21 18:00:18
Documents
1
Period of Report
2023-08-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4278
  Complete submission text file 0001493152-23-029734.txt   5718
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 855 N WOLFE STREET #623-6 BALTIMORE MD 21205 813-369-5150
MIRA PHARMACEUTICALS, INC. (Issuer) CIK: 0001904286 (see all company filings)

IRS No.: 853354547 | State of Incorp.: FL
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MIRA PHARMACEUTICALS, INC. 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606-2173
Business Address
Nicholoudis Christos (Reporting) CIK: 0001984816 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41765 | Film No.: 231190452